BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8164383)

  • 1. [Hormone replacement therapy].
    Nozue E
    Nihon Rinsho; 1994 Mar; 52(3):787-92. PubMed ID: 8164383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical issues and hormone replacement therapy.
    Harris PF
    Curr Womens Health Rep; 2002 Oct; 2(5):373-81. PubMed ID: 12215310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of estrogen and gestagen substitution in peri and postmenopause].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone therapy for the menopause.
    Gambrell RD; Greenblatt RB
    Geriatrics; 1981 Jul; 36(7):53-61. PubMed ID: 7239166
    [No Abstract]   [Full Text] [Related]  

  • 9. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
    Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing Mirror clinical forum 7. Hormone replacement therapy.
    Fish S
    Nurs Mirror; 1983 Aug; 157(6):suppl i-vii. PubMed ID: 6554776
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Stevenson JC
    Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and health protection.
    Chiechi LM
    Curr Opin Investig Drugs; 2003 Apr; 4(4):439-43. PubMed ID: 12808884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.